Organogenesis Holdings Inc. (ORGO) Profit Margins
Over the twelve months to 2026-06-30, Organogenesis Holdings Inc. (ORGO) had operating margin -7.8%, net margin -18.4%, free cash flow margin 4.6%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ORGOOrganogenesis Holdings Inc.Follow ORGO — free
—
Price chart with a free account
- Market cap
- 127.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 64.4% | 70.9% | 74.2% | 75.6% | 76.7% | 75.4% | 76.0% | — | — | |
| Operating margin | -26.7% | -11.4% | 7.9% | 15.5% | 4.9% | 2.9% | -0.3% | 7.9% | -7.8% | |
| Net margin | -33.5% | -14.8% | 5.1% | 20.2% | 3.4% | 1.1% | 0.2% | 6.6% | -18.4% | |
| FCF margin | -32.3% | -15.1% | -3.6% | 6.6% | -2.0% | 1.5% | 0.9% | -4.3% | 4.6% |
USD millions · SEC XBRL
Organogenesis Holdings Inc. — questions
- What is Organogenesis Holdings Inc.'s operating margin?
- -7.8% over the twelve months to 2026-06-30.
- What is Organogenesis Holdings Inc.'s net profit margin?
- -18.4% over the twelve months to 2026-06-30.
Every figure on this page comes from Organogenesis Holdings Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.